Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
出版年份 2023 全文链接
标题
Once-weekly bortezomib as the standard of care in multiple myeloma: results from an international survey of physicians
作者
关键词
-
出版物
Blood Cancer Journal
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-11-06
DOI
10.1038/s41408-023-00937-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Multiple myeloma with acute light chain cast nephropathy
- (2023) Nelson Leung et al. Blood Cancer Journal
- Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
- (2022) Georgia J. McCaughan et al. BRITISH JOURNAL OF HAEMATOLOGY
- Triplet Therapy, Transplantation, and Maintenance until Progression in Myeloma
- (2022) Paul G. Richardson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Daratumumab, Lenalidomide, Bortezomib, & Dexamethasone for Transplant-eligible Newly Diagnosed Multiple Myeloma: GRIFFIN
- (2020) Peter M Voorhees et al. BLOOD
- Longer term follow-up of the randomized phase III trial SWOG S0777: bortezomib, lenalidomide and dexamethasone vs. lenalidomide and dexamethasone in patients (Pts) with previously untreated multiple myeloma without an intent for immediate autologous stem cell transplant (ASCT)
- (2020) Brian G. M. Durie et al. Blood Cancer Journal
- Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial
- (2020) Shaji K Kumar et al. LANCET ONCOLOGY
- Outcomes with different administration schedules of bortezomib in bortezomib, lenalidomide and dexamethasone ( VRd ) as first‐line therapy in multiple myeloma
- (2020) Joselle Cook et al. AMERICAN JOURNAL OF HEMATOLOGY
- The effects of different schedules of bortezomib, melphalan, and prednisone for patients with newly diagnosed multiple myeloma who are transplant ineligible: a matching-adjusted indirect comparison
- (2019) Maria-Victoria Mateos et al. LEUKEMIA & LYMPHOMA
- Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
- (2018) María-Victoria Mateos et al. NEW ENGLAND JOURNAL OF MEDICINE
- Lenalidomide, Bortezomib, and Dexamethasone with Transplantation for Myeloma
- (2017) Michel Attal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neuropathy and efficacy of once weekly subcutaneous bortezomib in multiple myeloma and light chain (AL) amyloidosis
- (2017) Surbhi Sidana et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search